Yongfeng Wei

Targeting Tumor Angiogenesis with Histone Deacetylase Inhibitors: the Hydroxamic Acid Derivative LBH589

David Z. Qian, Yukihiko Kato, Shabana Shabbeer et al. · Clinical Cancer Research · 2006 · 272 citations

The Histone Deacetylase Inhibitor NVP-LAQ824 Inhibits Angiogenesis and Has a Greater Antitumor Effect in Combination with the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor PTK787/ZK222584

David Z. Qian, Xiaofei Wang, Sushant K. Kachhap et al. · Cancer Research · 2004 · 229 citations

Tumor Biology, Greater Antitumor Effect, Inhibit Tumor Growth +15

Identification of Type 1 Inosine Monophosphate Dehydrogenase as an Antiangiogenic Drug Target

Curtis R. Chong, David Z. Qian, Fan Pan et al. · Journal of Medicinal Chemistry · 2006 · 97 citations

Antiangiogenic Drug Target, Type 1, Angiogenesis +16

Epigenetic Modulation of Retinoic Acid Receptor β2 by the Histone Deacetylase Inhibitor MS-275 in Human Renal Cell Carcinoma

Xiaofei Wang, David Z. Qian, Mingqiang Ren et al. · Clinical Cancer Research · 2005 · 75 citations

Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-<i>cis</i>-retinoic acid in human malignant melanoma

Yukihiko Kato, Brenda Salumbides, Xiao-Fei Wang et al. · Molecular Cancer Therapeutics · 2007 · 74 citations · Full text